No insider purchase over the last 90 days. The latest, by Pun Yue Wai, was filed 08 Dec 2025.
Jacobson Pharma Corporation Ltd. is a listed company. Its directors and officers file their transactions with HKEX. 3 insiders have disclosed 6 filings since 19 October 2025.
Not one open-market sale was filed. On the buying side, 3 insiders reported 3 purchases. No amount is published for 3 filings, which the totals therefore leave out. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Those buying include 3 senior executives.
For context, the typical company on the same exchange (median of 1,323 companies) published 4 filings over the same period, against 6 filings here. Our records for Jacobson Pharma Corporation Ltd. go back to 2017, with 142 purchases and 13 sales on the open market in total.
The most recent open-market purchase was published on 8 December 2025, 317 days ago. Typically, a trade is published a median of 2 days after it takes place. The shorter that gap, the sooner other investors can see what insiders have done.
Elsewhere in the same market, our signals recently picked up insider purchases at Sun Hung Kai Properties Ltd. and Xinyi Glass Holdings Ltd. This summary is built from HKEX disclosures alone and does not predict where the share price will go.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended March 2026 · cache
25 of 182 declarations
Purchases our model currently ranks for the recommendations list.
All recommendations